Categories: Breast Cancer Treatment Tags: Advisory, Avastin, Committee, From, Meeting, Provides, Roche, Update
Roche drugs point to personalized lung cancer care
Roche drugs point to personalized lung cancer care
Roche’s experimental drug MetMab and its established product Tarceva showed impressive results in lung cancer trials on Saturday, highlighting how treating the disease is becoming much more focused.
Read more on Reuters via Yahoo! News
Categories: Breast Cancer Tumor Tags: cancer, Care, Drugs, lung, Personalized, point, Roche
Roche provides update on FDA application for T-DM1
Roche provides update on FDA application for T-DM1
Roche expects a global regulatory submission mid 2012. Roche today announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company’s trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will…
Read more on Manufacturing.net
Categories: Breast Cancer Tumor Tags: application, Provides, Roche, TDM1, Update
Roche half-year profit rises 37 percent to $5.3B
Roche half-year profit rises 37 percent to $5.3B
Pharmaceuticals maker Roche Holding AG on Thursday posted a 37 percent rise in six-month net profit on strong drug sales and lower costs related to its takeover of U.S.-based Genentech.
Read more on WXOW 19 La Crosse
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance